About
136,900.00KRW+500.00 +0.37%
Closed • Updated at 17:04 GMT+00:00Market Cap$3.57B
P/E Ratio13.43
Volume160.6K
Beta0.22
RSI48.50
Gross Margin35.90%
Orion Corp. — investor relations, events, news, and company updates on 6ix.
Latest News
May 15 2026
105,950 Orion Corporation A shares converted into B shares
Apr 27 2026
Composition of the Nomination Committee of Orion Corporation
Apr 23 2026
Orion Group Interim report January–March 2026
Apr 23 2026
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
Apr 20 2026
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
Community Chat
Ask AI
Try asking
Translate